| Literature DB >> 24600647 |
Bajic Vladan1, Spremo-Potparevic Biljana2, Vesna Mandusic3, Milicevic Zorana3, Lada Zivkovic2.
Abstract
Years ago, it was thought that a genetic component was the fundamental cause of a number retinopathy diseases including age related macular degeneration (AMD). Since then, information has emerged about novel genes that contribute to various forms of AMD and other retinopathies that have been eluding researchers for years. In the genetic sense, only the APOE 2 and 4 genes have been found to be a risk factor for sporadic AMD. But, a recent Genome wide association study (GWAS) revealed that an alteration of five SNIPs on the X chromosome in a gene named DIAPH2 may be a susceptibility gene for AMD. Furthermore, the gene DIAPH2 showed to have a polygenic pleiotropy for premature ovarian failure (POF) and AMD in a cohort of women. POF is highly associated with X chromosome skewing, an epigenetic alteration of the inactivation process of the X chromosome. These findings suggest a hypothesis that an epigenetic alteration on the inactivation centres of the X chromosome (or skewing) relates not only to aging, but might be a novel property that affects women with AMD more often than men.Entities:
Keywords: AMD; DIAPH2 Gene; X Chromosome; X Chromosome Skewing
Year: 2013 PMID: 24600647 PMCID: PMC3939760
Source DB: PubMed Journal: Med Hypothesis Discov Innov Ophthalmol ISSN: 2322-3219
X chromosome linked Retinopathies
|
|
|
|
|---|---|---|
| Xp22.2 | Jobert syndrome; X-linked retinitis pigmentosa, severe; genomic next-generation sequencing also uncovered a deep intronic mutation in a family with severe X-linked RP (the RP23 locus) | [18] |
| Xp21.33 | AMD and premature ovarian failure, near the DIAPH2 gene, which is known to cause premature ovarian failure (POF) in females | [3] |
| Xp22.13 | Retinoschisis; protein: retinoschisin expression is limited to photoreceptors but protein is secreted into the inner retina | [19] |
| Xp21-q21 | Retinitis pigmentosa with mental retardation | [20] |
| Xp21.3-p21.2/ Xp11.4 | X-linked retinitis pigmentosa | [21- |
| Xp21.2-p21.1 | Oregon eye disease, candidate gene; exons 20-28 involved in retinal disease | [23- |
| Xp11.4 | X-linked congenital stationary night blindness; protein: nyctalopin | [25- |
| Xp11.3-p11.23 | retinal dysplasia, primary linked to the Norrie disease | [27] |
| Xp11.23 | X-linked progressive cone-rod dystrophy; protein: L-type voltage-gated calcium channel alpha-1 subunit | [28] |
| Xp11.23 | protein: retinitis pigmentosa 2 (X-linked) | [29] |
| Xq21.1 | Retinitis pigmentosa with myopathy; protein: phosphoglycerate kinase | [30] |
| Xq22.1 | optic atrophy, protein: inner mitochondrial membrane translocase 8 homolog A., protein involved in transport of metabolites into mitochondria | [31] |
| Xq26-q27 | X-linked retinitis pigmentosa | [32] |
| Xq27 | X-linked progressive cone dystrophy, genetic heterogeneity underlying this disease entity | [33] |
| Xq28-qter | X-linked retinitis pigmentosa | [34] |
| Xq28/Xq28 | Rare macular dystrophy in blue and red cone monochromacy with loss of locus control element; protein: green cone opsin and red cone opsin | [35] |
* X chromosome ideogram based on G-bands with approximate location of the centromere region
Figure 1AMD is shown to be a consequence of a complex process of intertwining genetic, epigenetic and environmental factors with aging